Technology Accelerator Fund News
UB materials science professor’s insulation innovation was inspired by the structure of the pores of human skin.
Iron-based contrast agent technology may offer an affordable and abundant alternative to rare earth element.
SUNY Downstate scientists’ flash of insight was based on a unique discovery they made about an unforeseen pathway in the immune system.
UAlbany technology uses a mobile Internet of Things sensor network to track government owned infrastructure and properties.
The cleantech Most Valuable Pitch competition featured presentations from ten early stage companies working in solar, wind, biofuels, energy storage and more.
The day-long event hosted by UAlbany’s SBDC featured workshops and the first TAF Most Valuable Pitch competition.
First ever TAF Most Valuable Pitch competition featured 10 SUNY-affiliated startup companies.
SUNY startup Verdimine is trying to increase production of imines, compounds that contain a carbon-nitrogen double bond, from lab-scale to manufacturing-scale.
Downstate vision scientists are developing a system that can objectively, precisely, and universally track eye movements.
Mechanismic previously received a SUNY Technology Accelerator fund investment to advance its state-of-the-art design-driven robotics and STEM education product.
Binghamton University chemist Chuan-Jian Zhong engineered a new alloy from the atomic level up.
The technology is unique in that it can identify Alzheimer’s disease without extensive testing using brain imaging technologies or spinal fluid extractions.
Over $200,000 invested to spur commercialization at six campuses.
Launched at SUNY Geneseo in 2013, the VentureWorks Entrepreneurship Program.
The path Dr. Fabris followed in winning the TAF investment indicates a new direction for scientists doing basic research.
The discovery of an RNA molecule could provide the basis for treating high cholesterol and atherosclerosis.
For years, scientists have been searching for ways to reduce the debilitating side effects of anti-cancer drugs. At Binghamton University, Susan Bane thinks she
The research behind the nanoparticle was funded by grants from the NIH, the National Heart Lung and Blood Institute and SUNY's Technology Accelerator Fund.
SUNY Oswego inventor will use a $50,000 investment from SUNY’s Technology Accelerator Fund to build and test a prototype device.
An interdisciplinary team develops an idea that could revolutionize healthcare.
A SUNY researcher has made clinically available a blood test that is useful in the diagnosis and treatment of several pregnancy-related disorders.
SUNY Technology Accelerator Fund investment advances promising therapy.
Device developed at Stony Brook is the first Technology Accelerator Fund (TAF) project to go to market.
Passive solar systems currently employ metal coatings, rather than dyes. ChromaNanoTech plans to incorporate its light-filtering dyes into the plastic itself.
Chris Nomura and his team have engineered E. coli bacteria to produce special polymers that serve as the vehicles for delivering cancer drugs.
University at Albany researcher partners with BioTools to improve crime scene investigations.
The new set of cognitive tests will help doctors and clinicians properly diagnose and manage concussions.
Dr. Mark Stewart re-purposed a vagus nerve stimulator to use the body's nervous system to re-start the heart in a lower-power, more stable alternative to ICDs.
The new therapeutic could be taken in once-weekly doses rather than existing medications that are injected multiple times a day.
Cytocybernetics demonstrates how TAF, START-UP NY and other technology/economic development programs help small businesses grow.
Novel use of nerve conduction data and computer-based analytics provides a better understanding of nerve damage.
SUNY Buffalo State professor invents a new type of video game controller that allows users to manipulate 3-D objects.
New technology that could help patients regrow blood cells after chemotherapy, radiation, or bone marrow transplants may also treat obesity.
Prototype developed by UAlbany’s Rabi Musa saves time and prevents loss of valuable – in some cases, priceless – samples.
TAF investment supports proof-of-concept studies to determine the radiance and fluency of light needed to decrease the growth of pathogens.
Technology could cut in half the time and money needed for pre-clinical trials for new medications.
Glauconix, Inc, which has attracted $575,000 in grants and investments since its founding, is climbing steadily toward its commercial debut.
New companies are advancing innovation in health care and energy efficiency.
Successive TAF awards provide an important boost, enabling the new technology to attract additional support.
SUNY Technology Accelerator Fund invests in treatment that may just take breast cancer cells and turn them off.
The invention can form materials and devices as small as a single atom, and then measure their properties with a high degree of resolution.
Laser based body heater increases weight loss and productivity.
Optical dyes that are both economical and stable are about to hit the market, thanks to some researchers at Binghamton University.
New fiber optic probe could aid in the management of aortic aneurysms, spinal cord trauma, and spine reconstructive surgery.